After seeing the market for his services dwindle for nearly the entire offseason, Michael Bourn has finally found a home.
According to Jon Heyman of CBS Sports, Bourn has agreed to a contract with the Indians. The deal is worth $48 million over four years and includes a vesting option for a fifth year which could push the total to $60 million.
Bourn originally hoped to land a deal north of the five-year, $75.25 million contract B.J. Upton signed with the Braves, so this looks like a relative bargain in comparison. Still, Scott Boras deserves credit for getting a pretty good deal for his client given the circumstances. While the Mets were reluctant to give up their first-round pick (11th overall) and draft pool money to sign Bourn, Cleveland’s first-round pick is protected. The Indians forfeited their second-round pick to sign Nick Swisher, so Jim Callis of Baseball America hears that they’ll give up their competitive balance pick (No. 69 overall) to bring Bourn into the fold.
The Indians were mentioned as a possibility for Bourn as recently as last week, so this doesn’t come completely out of nowhere. However, it seemed like a long shot at the time given that Swisher, Michael Brantley and Drew Stubbs were already in-house for the outfield. It’s a pretty good bet that Bourn, Swisher and Brantley will be in the lineup on most days, though Swisher and Mark Reynolds could alternate between first base/DH duties, opening up a spot for the speedy Stubbs in right. The Indians could also explore trades involving Stubbs. All in all, it’s a pretty nice problem to have. I don’t think the Indians have enough pitching to threaten the Tigers in the AL Central, but it looks like Terry Francona’s first year as skipper will be an interesting one.
UPDATE: According to Joel Sherman of the New York Post, the Mets also made a four-year, $48 million offer to Bourn. However, they were informed that it would take an arbitrator two to three weeks to decide whether they would be able to keep their first-round pick. And with spring training approaching, Bourn just wasn’t willing to wait that long, so he took the Indians’ deal.
Pirates pitching coach Ray Searage has become the king of the reclamation project. And it sounds like he’s about to take on another big one …
Travis Sawchik of the Pittsburgh Tribune-Review reports that the Pirates have expressed interest in free agent Justin Masterson. The expectation is that it will be a one-year deal with the goal of rebuilding the right-hander’s value in an environment where many other struggling veteran pitchers have executed significant career turnarounds.
Masterson earned his first (and only) All-Star nod in 2013 when he registered a 3.45 ERA, 195 strikeouts, and three shutouts in 32 appearances with the Indians. But he had a 5.88 ERA in 128 2/3 innings between Cleveland and St. Louis in 2014 and he continued struggling to the tune of a 5.61 ERA with the Red Sox in 2015.
It’s not clear whether the Bucs would try him as a starter or reliever.
Jordan Zimmermann signed with the Tigers on Sunday for five years, $110 million. David Price signed with the Red Sox on Tuesday for seven years, $217 million.
Two big dominos have fallen in this loaded free agent market for starting pitchers, and another big one is about to go …
FOX Sports’ Ken Rosenthal says a deal for Zack Greinke “could come soon” and it’s currently “Dodgers vs. Giants” at the top of the bidding ladder.
ESPN’s Jerry Crasnick confirms that both the Dodgers and Giants are looking for an answer from Greinke, adding that the 32-year-old right-hander seeks a five- or six-year deal with a greater average annual value (AAV) than what Price just secured from Boston. That number would be $31 million, so we’re talking something close to $32 million through 2020-2021.
Greinke opted out of the remaining three years and $71 million contract with Los Angeles in October after posting a 1.66 ERA and 0.84 WHIP across 222 2/3 regular-season innings in 2015. He finished second to the Cubs’ Jake Arrieta in the National League Cy Young Award balloting.
Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.
This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.
Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.
The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.
MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.
The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:
- Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
- 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
- The previous year there were 7,929 total tests with 12 which resulted in discipline;
- There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.
A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.
As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.